5 completed, 3 active not recruiting, 2 recruiting. 10 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 10 | Completed 5, Active not recruiting 3, Recruiting 2 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Servier: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 3 Study of Vorasidenib (S095032/AG-881) in Asian Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 orIDH2 Mutation Vorasidenib, Placebo - Residual or Recurrent Grade 2 IDH Mutant Glioma | Phase 3 | Active not recruiting | Servier | 57 | 2024-10-18 | 2026-06-04 |
| Personalized Medicine for Advanced Biliary Cancer Patients Futibatinib, Ivosidenib, Zanidatamab - Biliary Tract Neoplasms | Phase 3 | Recruiting | UNICANCER | 800 | 2024-07-18 | 2026-05-19 |
| A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia Omitted Doxorubicin, Omitted Vincristine+Dexamethasone pulses, Inotuzumab Ozogamicin+Standard Maintenance Therapy - Leukemia, Acute Lymphoblastic | Phase 3 | Recruiting | Mats Heyman | 6430 | 2020-07-13 | 2026-08-12 |
| Evaluation of the Clinical Efficacy and Safety of Amlodipine 5mg/ Bisoprolol Fumarate 5mg /Perindopril Arginine 5mg Fixed-dose Combination in Capsule and Free Monotherapy at the Same Dose in Patients With Uncontrolled Essential Hypertension. Amlodipine 5mg + bisoprolol fumarate 5mg + perindopril arginine 5mg, Norvasc 5mg tablet, Concor 5mg tablet - Essential Hypertension | Phase 3 | Completed | Servier | 150 | 2018-05-14 | 2025-06-05 |
| Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma Prednisone, Vincristine, Daunorubicin - Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma | Phase 2 / Phase 3 | Active not recruiting | St. Jude Children's Research Hospital | 790 | 2017-03-29 | 2026-06-17 |
| Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents Pegaspargase, Erwinia asparaginase, Cyclophosphamide - Acute Lymphoblastic Leukemia, Pediatric | Phase 3 | Active not recruiting | Dana-Farber Cancer Institute | 560 | 2017-03-03 | 2026-07-16 |
| Is There a Benefit to Optimize Heart Failure (HF) Treatment in Aged Over 80 Year's Old Patients? - Angiotensin conversing enzyme inhibitors: enalapril, captopril, lisinopril, ramipril, trandolapril. - Heart Failure | Phase 3 | Completed | University Hospital, Clermont-Ferrand | 35 | 2011-08-01 | 2014-10-01 |
| Perindopril vs Ramipril for Persistence in MAU Reduction Study ramipril, perindopril - Diabetes, Microalbuminuria | Phase 3 | Completed | Sunnybrook Health Sciences Centre | 23 | 2010-04-01 | 2016-04-06 |
| Comparison Between Fotemustin to Intensive Surveillance in Patients With High Risk Uveal Melanoma Adjuvant chemotherapy by Fotemustin, Intensive surveillance - Uveal Melanoma | Phase 3 | Completed | Institut Curie | 302 | 2009-06-23 | 2022-08-31 |
| Efficacy of Perindopril to Prevent Recurrence of Atrial Fibrillation in Patients With Essential Hypertension Perindopril - Essential Hypertension, Atrial Fibrillation | Phase 3 | Completed | Montreal Heart Institute | 316 | 2007-12-01 | 2020-02-21 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma (3) · Essential Hypertension (2) · Leukemia (2) · Atrial Fibrillation (1) · Biliary Tract Neoplasms (1) · Diabetes Mellitus (1) · Heart Failure (1) · Lymphoma (1) · Uveal Melanoma (1)
Perindopril (3) · Asparaginase (2) · Calcium Dobesilate (2) · Cyclophosphamide (2) · Cytarabine (2) · Dasatinib (2) · Dexamethasone (2) · Doxorubicin (2) · Etoposide (2) · Mercaptopurine (2) · Methotrexate (2) · Ramipril (2) · Vincristine (2) · asparaginase erwinia chrysanthemi recombinant (2) · blinatumomab (2)
France (4) · Canada (3) · Belgium (2) · United Kingdom (2) · United States (2) · Australia (1) · China (1) · Denmark (1) · Estonia (1) · Finland (1) · Germany (1) · Iceland (1) · Ireland (1) · Lithuania (1) · Netherlands (1)
Alexandra Konradi (1) · Hiroto Inaba, MD, PhD (1) · Ivan Borbath, MD (1) · John Bridgewater, MD (1) · Juan W Valle (1) · Julien Edeline, MD (1) · Malka David, MD (1) · Mario Talajic, MD (1) · Mats Heyman, MD, PhD (1) · Melissa Burns, MD (1)
PMID 12493255, PMID 22394464, PMID 34933343, PMID 35501736, PMID 40905823, PMID 41469545, PMID 42154791